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AN INITIATIVE TO REDUCE HOSPITAL READMISSIONS:  
 
MOVING TOWARDS A LEARNING HEALTH SYSTEM 
 





Avoidable readmissions to the hospital present a significant challenge for health systems 
with an estimated $41.3 billion per year in additional healthcare spending attributed to 
unnecessary rehospitalization. Existing interventions targeting readmissions shows mixed 
evidence of effectiveness and context dependent success for certain strategies. This study 
is a pragmatic evaluation of the effectiveness of a hospital-wide readmission reduction 
initiative at Boston Medical Center (BMC), a large safety-net hospital, with the goal of 
advancing a Learning Health System model.   
 
Methods 
Adult patients admitted to BMC were risk stratified using a proprietary algorithm into 
one of four risk groups: Low Risk (LR), Moderate Risk (MR), High Risk (HR) and Super 
Utilizer (SU). The MR, HR and SU groups were each assigned to receive a different 
bundle of evidence-informed readmission reduction interventions.  We used a quasi-
experimental design combining principles of Regression Discontinuity and Difference-in-
Difference to estimate the effect that each of the three bundles had on a 30-day 
readmission outcome. Patient visits from February 2015 to January 2016 were included 
in the pre-implementation period and visits from November 2016 to October 2017 in the 
	
v 
post-implementation period.  
 
Results 
There were 18,634 patient visits included in the pre-intervention period and 10,714 
observations in the post-implementation period. We found no significant effect for any of 
the three bundles of interventions with adjusted pre-post changes in 30-day readmission 
of 2.67% (95%CI: -1.27, 6.61) for the MR group, 1.02% (95%CI: -4.65, 6.68) for the HR 
group and 8.07% (95%CI: -4.33, 18.46) for the SU group.  
 
Discussion 
The interventions in the BMC readmissions reduction initiative were not successful in 
reducing readmission rates for any of the targeted risk groups. Further work is needed to 
identify specific factors in the design and implementation of the interventions that limited 
their effectiveness. However, the results of this evaluation can be used to guide iterative 
improvement for future readmission reduction efforts.  Additionally, the analytic strategy 
used in this study provides a model for hospitals to develop Learning Health System 
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Health systems in the United States increasingly face pressure to address the triple aim of 
improved quality of care and patient experience at lower cost. As systems move towards 
value-based care delivery models, there are strong financial incentives to reduce 
overutilization of intensive inpatient services. Such efforts frequently take the form of 
decreasing the number of avoidable readmissions to the hospital. Interventions to 
decrease hospital readmissions are complex, costly and context dependent.  The problem 
of avoidable readmissions therefore provides an opportunity to realize the benefits of a 
learning health system (LHS). First articulated by the Institute of Medicine in 2012, a 
LHS is defined as “[a] health care delivery system that combines research, data science, 
and quality improvement, yielding knowledge as a by‐product of the patient–clinician 
interaction” 1.  Application of up-to-date, evidence-based practices and leverage of 
advanced information technology (IT) solutions are components of an LHS, but what 
distinguishes the LHS model is a need to “continually assess outcomes, refine processes 
and training to create a feedback cycle for learning and improvement” 2.  The ability to 
pragmatically assess outcomes, promptly, at low cost and with improved causal 
inference, is vital to developing the capacity of a LHS.  
 
This rigorous evaluation of a hospital-wide readmission reduction effort at Boston 
Medical Center (BMC) provides a model for assessment of a large-scale quality 






Significance of Hospital Readmissions  
Readmissions to the hospital after inpatient discharge represent immense costs 
financially—the Agency for Healthcare Research and Quality in 2011 estimated that the 
approximately 3.3 million readmissions lead to $41.3 billion in additional healthcare 
cost3—and presents risk to patients who face additional dangers from nosocomial 
infection and other inpatient safety risks. The Medicare Payment Advisory Commission 
(MedPAC) reported in 2014 that even a modest 10% reduction in the number of 
avoidable hospital readmissions could save the Medicare program over $1 billion 
annually4.  
 
In 2012, the Centers for Medicare and Medicaid Services (CMS), as part of the Hospital 
Readmission Reductions Program (HRRP), began to tie hospital reimbursements to 
performance on measures of risk-adjusted 30-day readmissions for certain high-risk 
conditions and these 30-day readmission rates were included as a component of the CMS 
Star Rating system for hospital quality5.  CMS subsequently expanded its public 
reporting and rating framework to include not only disease-specific readmission rates, but 
also a risk-adjusted measure of hospital wide all-cause 30-day readmission rate6. 
However, due to language in the Affordable Care Act, the all-cause readmission measure 
was not incorporated into the HRRP financial penalty structure. The recent changes in 
payment and reporting heightened the salience of readmission measures to health systems 




Reliable national data for readmission rates across all-payers are limited. Studies of 
Medicare populations have estimated that up to 19.6% of discharged patients were re-
hospitalized within 30 days8 and that rate appears to be slowly decreasing since 20129.  
However, the degree to which this decline can be fully linked to improvement in hospital 
practices, versus changes in coding or other confounders, remains controversial.10  
 
Despite reporting definitions that measure readmissions irrespective of cause, not every 
such event represents poor quality medical care, nor can every readmission necessarily 
have been prevented. The estimated proportion of readmissions that should be classified 
as avoidable varies widely, from 9% to 48%11.  There are significant efforts to ascertain 
the modifiable factors that influence avoidable readmissions and to leverage them to 
target effective interventions.  
 
The underlying cause of hospital readmission is multifactorial and may vary among 
different patients or institutions. Researchers have recognized numerous factors affecting 
risk for re-hospitalization, including patient characteristics, institutional characteristics 
and, perhaps most importantly for a health system seeking to improve performance, 
deficiencies in patient care and poor transitions of care.  In terms of patient 
characteristics, socioeconomic status12, race13, age14, health literacy15, history of trauma16, 
degree of comorbid illness17, code status18 and polypharmacy19 have all been identified as 
contributing to increased readmission risk. When looking at institutional characteristics, 




adjustment for disease severity20,21. Deficiencies in care, especially related to medication 
errors, are a major modifiable contributor to readmissions. Missing or incorrect 
prescriptions, patient misunderstanding and inadequate monitoring are all cited as 
common lapses increasing risk of subsequent re-hospitalization22.  Disorganized 
transitions from the inpatient to outpatient phase of care, including poor communication 
between inpatient and outpatient providers23, limited patient support after discharge22 and 
delayed outpatient follow-up24,25 have been identified as additional risk factors for 
readmission to the hospital.   
 
Evidence for Readmission Reduction Interventions  
The structure of the HRRP ensured that early efforts at readmission reduction were 
frequently condition-specific, targeting the high-risk disease cohorts identified by CMS.  
As public reporting and quality rating expands to include overall all-cause readmission, 
health systems have begun to develop initiatives that target all patients at risk of 
readmission. It is important to consider that while disease-specific interventions share 
characteristics—such as enhanced care coordination—that may be broadly applicable, the 
exact degree to which their results are generalizable to wider populations remains 
unclear.   
 
There are frequently contemporaneous efforts to improve general inpatient safety and 
quality of care that can have indirect effects on whether the patient returns to the hospital 




care. A 2011 systematic review found that studies of existing interventions often used 
weak study designs, lacked sufficient descriptive detail to fully understand the 
intervention and most showed null or heterogeneous results, making it difficult to draw 
clear conclusions26. However, the authors identified 16 well-designed randomized 
clinical trials of which 5 showed a significant decrease in readmission rates. Among these 
successful studies, most involved bundles of interventions and only two components were 
shared across these trials: redesign of discharge paperwork to create patient centered 
discharge instructions and a post-discharge phone call to the patient. Subsequent 
systematic reviews have found successful interventions tend to have multiple 
components, support a patient’s capacity for self-care and that the largest benefits accrue 
to the most complex individuals27,28.  
 
Not all readmission interventions are benign. One randomized trial in the VA population 
found that an intervention consisting of close clinician contact and follow-up after 
discharge paradoxically increased the rate of hospital readmissions29. Another review of 
hospital strategies for reducing readmissions for heart failure suggested increased rate of 
readmission for certain interventions that feature enhanced post-discharge contact with 
clinicians30. These paradoxical results indicate that coordination efforts in certain 
circumstances such as post-discharge contact with a clinician may either (1) lower the 
threshold for re-hospitalization, leading to more avoidable readmissions or (2) uncover to 





There is also a much smaller evidence base for successful readmission prevention 
interventions in the safety-net setting. While some of the general strategies outlined 
above may be applicable, validating their effectiveness in such a setting remains an 
unmet priority. One well-designed randomized trial tested a bundle of interventions, 
including a nurse discharge advocate, redesigned discharge instructions and a post-
discharge pharmacist call, showed an absolute reduction of 6% in 30-day readmissions at 
an urban safety-net hospital31.  However, a nurse led initiative that included intensive 1-
on-1 education and a post-discharge phone call failed to show any improvement in a 
randomized trial among a diverse group of elderly patients discharged from a safety-net 
hospital32.  Another study testing patient navigation in the safety-net setting showed a 
decrease in composite utilization, but failed to significantly reduce a hospital readmission 
outcome and in fact, among a subgroup of patients <60 years old, the intervention 
appeared to increase readmissions33.     
 
Gap in the Literature  
There is a relative paucity of literature on the effect of a large-scale integrated 
readmission reduction efforts in a safety-net setting and there is a need for innovative 
approaches to pragmatically assess such efforts as a means of advancing a learning health 
system.  
 
The factors driving readmissions may differ for safety-net hospitals and observational 




frequently, they still have less robust readmission reduction efforts than their non-safety-
net peers34.  Thus there is an imperative to expand the evidence base of effective 
interventions and strategies for a safety-net population and to move beyond individual 
interventions to examine outcomes in the context of an entire institutional readmission 
reduction policy.   
 
There is a large body of evidence in the Implementation Science literature that suggests 
the context of an intervention plays a significant role in its relative success or failure35.  
Institutions cannot simply create a simulacrum of existing evidence-based interventions 
and expect it to be successful. Furthermore, readmission interventions have demonstrated 
mixed evidence of effectiveness and attempts to implement existing evidence-based 
interventions have shown paradoxical effects in a different context, at times appearing to 
increase readmissions36. There is an opportunity then, to develop an efficient means for 
health systems to pragmatically assess the effectiveness of readmission efforts within the 
institution and to use these insights to guide future learning and iterative improvement. 
This analytic model would provide a capability vital to the realization of a learning health 




Boston Medical Center is a 496-bed, academic hospital acting as the largest safety-net 




70% underrepresented minorities—and linguistically—30% non-native English 
speakers—diverse with high levels of economic deprivation, as more than 50% of 
patients have an annual household income below $20,40037.  Many BMC patients have 
experienced trauma38 and possess low health literacy39, which have both been identified 
as independent risk factors for hospital readmission.  
 
Since the first year of HRRP readmission penalties in 2013, BMC has been penalized by 
CMS for excess readmission for three consecutive years, ranging from 0.56-1% payment 
reductions40. The hospital had a history of multiple disparate department-specific efforts 
to reduce readmissions, as well as a strong research background in design-based solutions 
for readmission reduction31. However, in early 2016, senior hospital administration 
embarked on a new effort to create and implement a robust, consistent initiative to target 
readmissions hospital-wide, with a substantial investment of resources. The overall 
strategy included development of a novel risk score to identify patients with the greatest 
need and implementation of a targeted bundle of evidence-based interventions.  
 
BMC Readmissions Strategy  
The details of the BMC Readmission Risk Score (Risk Score) are beyond the scope of 
this thesis. However, in brief, the BMC data analytics department used multiple logistic 
regression to analyze several prior years of clinical data from which they identified 15 
factors with the greatest contribution to readmission risk. Each of these factors was 




for a total possible aggregate score of 23.  The Risk Score was calculated automatically in 
the Electronic Medical Record (EPIC Systems, Inc.) and available when a patient was 
first admitted.  
 
The BMC administration then further stratified patients into one of four Risk Groups 
based on the individual’s numeric Risk Score.  Scores from 0-4 were considered “Low 
Risk”, scores from 5-9 were “Moderate Risk”, scores from 10-13 were “High Risk”, 
scores of 14 or more were “Super Utilizers”a.  The stratification strategy was chosen with 
the goal of roughly 80% of patients falling into the two lowest risk groups and 20% 
falling into the two highest risk groups.  
 
Beginning in February 2016, BMC designed and implemented a series of new 
interventions to reduce readmissions. The inventions were bundled and targeted based on 
a patient’s Risk Group with higher risk individuals receiving more intensive efforts 
(Table 2). All patients were affected by a hospital-wide re-design of standard discharge 
paperwork to simplify patient instructions and discharge medication lists. All patients 
Moderate Risk or above were assigned to receive a post-discharge phone call follow-up 
from a clinician; for Super Utilizers this post-discharge phone call was the responsibility 
of the Super Utilizer Team, described below. The High Risk bundle included the post-
discharge phone call as well as several additional policies and processes that occurred 
																																																													
a The original scoring structure categorized scores from 0-5 as “Low Risk” and 6-9 as “Moderate 
Risk”. However, due to a glitch in implementation, patients with a score greater than 4 were treated as 




during the inpatient stay and after discharge to enhance transitions of care. Existing 
inpatient pharmacists, case managers, nurses and social workers performed these tasks. It 
is important to note that while Risk Groups were used to guide delivery of these 
interventions, clinicians and staff were permitted to use their discretion to perform the 
tasks for patients not identified by score alone who may benefit.  
 
The effort targeting the highest risk Super Utilizers cohort was somewhat unique: they 
received all the intervention of High Risk bundle and were provided supplementary 
resources and attention in the form of a dedicated Super Utilizer Team. The Super 
Utilizer Team is a specialized multidisciplinary group that provides individualized, high-
touch case management—in addition to usual inpatient case management—to patients 
during their admission and after discharge. The team has significant flexibility and 
discretion to proactively identify patient needs— clinical, pharmaceutical, and 
psychosocial—and ensure consistent follow-up and communication.  
Given the significant staffing and infrastructure needs, implementation of the full BMC 
Readmission Reduction Program occurred gradually in February 2016 over a period of 
several months with full implementation completed by October of 2016.  
 
Conceptual Model  
Readmission to the hospital results from the interaction of multiple diverse etiologic 
factors that can differ among various institutions and between individual patients. This 




readmissions. For example, patients with greater underlying social and medical needs 
may respond differently than others to an intervention that increases contact with and 
access to providers after discharge. In this way, a structural change known to be effective 
in one institutional context may be less so for a health system serving a different patient 
population. Many readmission reduction programs are multifaceted, composed of several 
individual component interventions bundled together. They often occur in the setting of 
other concurrent pressures and efforts to reduce readmission both within and outside the 
institution.  These contextual factors complicate the ultimate goal of the present study: 
linking changes attributable to the BMC readmission reduction initiative to impact on the 
overall 30-day readmission, the ultimate outcome of interest.  
 
The classic framework for evaluating quality of care outlined by Donabedian41, provides 
a conceptual model to link the design and implementation of the BMC readmission 
reduction initiative to its effect on the readmission outcomes with the goal of enabling the 
articulation of specific lessons applicable to future improvement (Figure 1). Donabedian 
argues that quality can be measured using three interrelated dimensions of care. (1) 
Structure is the institutional context in which care is delivered and can include the 
physical infrastructure or equipment, the training, and availability of staff and 
administrative organization. (2) Process is concerned with the care or interventions 
delivered. (3) Outcome represents the ultimate quality endpoint of interest, whether that it 
be mortality, patient quality of life or readmission of the hospital42.  The putative 




structural changes influencing the type and quality of processes delivered to patients that 
then ultimately have an effect on health outcomes. Modifying the Donabedian framework 
to assess quality in the case of the BMC Readmission reduction initiative, there are two 
analytic approaches to assess the connection between structure, process and outcome.   
 
First, for patients in the Moderate Risk and High Risk cohort, structural changes in 
staffing and policies encourage performance of measurable new processes that are 
theorized to have an effect on the 30-day readmission outcome (Figure 1b). Quantifying 
the real-world delivery of these new processes provides a means by which to evaluate the 
link between structural policy changes and actual implementation of the processes. 
Furthermore, these novel processes were differentially applied to patients depending on 
their level of risk. This provides an opportunity evaluate their effect on readmission 
outcomes by comparing changes in the readmission rate near the Risk Group thresholds.  
 
Second, for the Super Utilizer cohort, there was a significant structural change with the 
creation of the Super Utilizer Team (Figure 1c). The Super Utilizer Team was given a 
broad mandate to address patient needs in a flexible manner with a wide array of possible 
services to deliver. Thus the exact processes of care delivered remain somewhat opaque 
and may change from patient to patient or evolve over time. A future qualitative study of 
the Super Utilizer Team implementation would be valuable to explore and delineate the 
actual process of care being delivered. However, because the team had a mandate to 




also be linked to the readmission outcome, again by comparing changes in readmission 
rate near the Super Utilizer risk threshold.   
 
Research Questions 
1. To what extent were the various components of the BMC Readmission Reduction 
Initiative for Moderate and High Risk patients actually implemented as planned? 
 
2. What effect did the readmission reduction initiative have on readmission rates among 
Moderate Risk, High Risk or Super Utilizer patients? 
 
Methods 
Data and Study Population  
The present study includes one year of historic data from February 2015 to January 2016, 
a period prior to the implementation of the BMC Readmission Reduction initiative and 
one year of post-implementation data from November 2016 to October 2017. Data during 
the period of program scale-up was excluded from analysis. Pre-implementation data was 
extracted from the BMC Clinical Data Warehouse and readmission risk scores were 
retrospectively calculated using the risk model outlined previously (Table 1). The same 
model was used to calculate risk scores in the post-implementation period using BMC’s 
electronic medical record (EPIC Systems, Inc.).  All patients admitted to adult inpatient 
wards at BMC over the study period were included in our study population. An 




Exposure, Outcome and Other Variables 
As noted above the exposure variables included a Post-Discharge Phone Call, the High 
Risk bundle or contact with the Super Utilizer Team with delivery of a particular 
intervention based on a patient’s Risk Group. Policy guidelines suggested that patients 
with a BMC risk score of 5 or greater receive a post-discharge phone call, all patients 
with a score of 9 or greater receive all components of the High Risk Bundleb and all 
patients with a score of 14 or greater have contact with the Super Utilizer Team (Table 
2).  
 
For each of the component interventions (exclusive of the Super Utilizer Team) in the 
BMC Readmission Reduction initiative, study personnel collected process metrics 
recording whether each task was performed or not, using a combination of automated 
EMR extraction and manual chart review. Process metrics were measured for: Pharmacy 
Admission Medication Reconciliation, Pharmacy Discharge Medication Reconciliation, 
Social Work Evaluation During Admission, Post-discharge Phone Call and Follow-up 
Appointment Made Prior to Discharge. Unfortunately, process metrics were not available 
for the Super Utilizer Team, although anecdotal evidence suggests the highest risk cohort 
of patients were near universally assigned to this team. 
 
																																																													
b The metric for post-discharge phone calls tracks performance of the phone call by the pharmacy 
staff. However, post-discharge contact was performed separately by the Super Utilizer team for 





The primary outcome for this study was all-cause 30-day readmission to Boston Medical 
Center as using the standard National Quality Forum (NQF)/CMS measure 
specifications43.  
 
Statistical Analysis  
Regression discontinuity (RD) is a quasi-experimental design that leverages the 
differential assignment of an intervention(s) based on the value of a continuous score to 
make inferences about the effect of the intervention around the score threshold44. 
Difference-in-difference (DID) is another quasi-experimental design that compares the 
change in an outcome pre- and post-implementation for two otherwise similar non-
randomized groups with a ‘treatment’ group receiving the intervention, and a ‘control’ 
group unexposed to the intervention. Controlling for the change in outcome from baseline 
for the control group compared to the change in baseline for the treatment group—i.e. a 
difference in difference—one can isolate and estimate the effect of the intervention 
itself45.  
 
The discrete nature of the BMC readmission risk score—patients can only score whole 
integers—and the fact that there is (by construction) a strong increasing relationship 
between risk score and the outcome means that patients just above and below the 
threshold are not exchangeable, which is the requirement in a regression discontinuity 
design46. However, the availability of historic pre-intervention data allows for the 




outcome. Although the RD assumptions47 may not apply to the raw data, there is strong 
reason to believe they would apply to the differences (over time for each value of the risk 
score). The same model (Table 1) was employed to calculate risk score in both the pre- 
and post-implementation period suggesting that individuals with the same score would be 
analogous in the pre- and post-implementation period. For example, a patient with a risk 
score of 9 in the pre-period is likely to be similar to a patient with a risk score of 9 in the 
post-period. Thus, the identification strategy utilizes is a hybrid of the RD and DID 
approaches. Given the random noise inherent in the data used to generate the risk score, 
as in RD, we assume that patients near either side of a cutoff—9 for the moderate 
risk/high risk threshold and 14 for the high risk/super utilizer threshold—are expected to 
be similar in unmeasured possible confounders after adjusting for pre-intervention 
differences. Patients scoring just below the threshold—and thus not assigned to receive 
the intervention(s)—can be treated as control or comparison group for those patients just 
above the threshold, who are assigned to receive the intervention, allowing for a form of 
DID analysis. Although our strongest inferences will be made just above and below the 
threshold, an advantage of the pre-intervention data is that it allows for difference-in-
difference style inference away from the threshold. As in any DID analysis, the 
identifying assumption is that the changes observed in the control group (below the 
threshold) are the same as the changes observed in the treatment group (above the 
threshold). Borrowing intuition from RD, this parallel trends assumption is most likely to 





We use an intention-to-treat analysis with treatment assignment determined by a patient’s 
risk group cohort (i.e. Low, Moderate, High or Super Utilizer) and estimated separate 
linear regression models for the readmission outcome at each of the three thresholds—
low/moderate risk, moderate/high risk and high risk/super utilizer. Each of the models 
included three terms: an indicator for the treatment (patient was assigned the post-
discharge phone call, the High Risk bundle or to the Super Utilizer team based on the 
value of the risk score), the pre/post variable (in this case prior to or after implementation 
of the re-admissions intervention), and the interaction term of treatment * post (which is 
the difference in difference estimator, or effect size), as well as a constant. Treatment 
effects (risk differences) were calculated for the Low/Moderate Risk threshold, the 
Moderate Risk/High Risk threshold and the High Risk/Super Utilizer threshold along 
with associated 95% CIs. Sensitivity analyses were performed using three different 
bandwidth data size around both cutoff points to ensure the validity of the results. 
Standard errors were clustered by patient to account for the fact that some patients 
contributed multiple observations. All analysis performed using R (Version 3.3.2).  
 
Results  
There were 18,634 patient visits included in the pre-intervention period and 10,714 
observations in the post-implementation period. The relative distribution of Risk Scores 






Process Measures Associated with the Moderate and High-Risk Interventions 
For the Moderate Risk intervention, Figure 3 shows the proportion of patients with an 
attempted post-discharge phone call binned by risk score. Performance of the discharge 
phone call increased at the low/moderate risk threshold, from 22.9% (95%CI: 11.8, 33.9) 
at a risk score of 4 to 51.8% (95%CI: 48.8, 54.8) at a risk score of 5. The proportions of 
patients receiving the various interventional components of the High Risk bundle are 
shown in Figure 4. The proportion of patients receiving a follow-up appointment prior to 
discharge, demonstrated no significant increase at the low/moderate risk threshold 
(Figure 4a).  The proportion of patients receiving an Admission Medication 
Reconciliation increased at the moderate/high risk from 10.5% (95%CI: 8.5, 12.4) as a 
risk score of 8 to 91.5% (95%CI: 89.2, 93.8) at a risk score of 9 (Figure 4b). The 
proportion of patients receiving a Discharge Medication Reconciliation increased at the 
moderate/high risk threshold from 6.4% (95%CI: 4.8, 8.0) at a risk score of 8 to 70.6% 
(95%CI: 66.8, 74.4) at a risk score of 9 (Figure 4c). The proportion of patients receiving a 
Psychosocial Evaluation by Social Work demonstrated no significant increase at the 
moderate/high risk threshold (Figure 4d).  
 
30-day Readmission Outcome: Low Risk/Moderate Risk Threshold 
Figure 5 shows graphically the readmission rate pre- and post-implementation (Figure 5a 
and 5b) and the difference (Figure 5c) in pre-post rates binned by Risk Score and with the 
Risk Group thresholds delineated. Table 3 presents the pre- and post-implementation 




difference results for the Low Risk/Moderate Risk threshold. Those with a Risk Score of 
4 (n=2103) had a pre-intervention 30-day readmission rate of 11.6% and a post-
intervention readmission rate of 12.0% for a pre-post difference of 0.45%. Patient with a 
Risk Score of 5 (n=2716) had a pre-intervention 30-day readmission rate of 11.2% and a 
post-intervention readmission rate of 14.3% for a pre-post difference of 3.12%. There 
was a non-significant difference-in-difference between the Risk Score of 4 and Risk 
Score of 5 with an effect size of 2.67% (95%CI: -1.27, 6.61) and p=0.18 suggesting no 
significant change in readmission rate versus what would have been expected in the 




30-day Readmission Outcome: Moderate Risk/High Risk Threshold 
Table	4	presents the pre- and post-implementation readmission rates for scores near the 
treatment cutoff, as well as difference-in-difference results for the Moderate Risk/High 
Risk threshold. Those with a Risk Score of 8 (n=2174) had a pre-intervention 30-day 
readmission rate of 19.6% and a post-intervention readmission rate of 20.8% for a pre-
post difference of 1.22%. Patient with a Risk Score of 9 (n=1291) had a pre-intervention 
30-day readmission rate of 19.6% and a post-intervention readmission rate of 21.8% for a 
pre-post difference of 2.24 %. There was a non-significant difference-in-difference 
between the Risk Score of 8 and Risk Score of 9 with an effect size of 1.02% (95%CI: -




would have been expected in the absence the High Risk interventions. 
 
30-day Readmission Outcome: High Risk/Super Utilizer Threshold 
Table	5	presents the pre and post-implementation readmission rates for scores near the 
treatment cutoff, as well as difference-in-difference results for the High Risk/Super 
Utilizer threshold. Those with a Risk Score of 13 (n=715) had a pre-intervention 30-day 
readmission rate of 39.4% and a post-intervention readmission rate of 36.7% for a pre-
post difference of -2.64%. Patient with a Risk Score of 14 (n=785) had a pre-intervention 
30-day readmission rate of 43.0% and a post-intervention readmission rate of 48.5% for a 
pre-post difference of 5.43 %. There was a non-significant difference-in-difference 
between the Risk Score of 13 and Risk Score of 14 with an effect size of 8.07% (95%CI: 




Overall the results from the intervention bundle process metrics suggest that the 
implementation of individual components of the BMC Readmission Reduction Initiative 
was uneven. Additionally, there was no significant decrease in 30-day readmissions 
attributable to the interventions for any of the Risk Groups.  
 




phone call, and admission/discharge medication reconciliations, were performed with 
high fidelity to the implementation plan, while others, such as scheduling of follow-up 
appointments, were rarely performed for any patients regardless of risk group. Three 
main patterns appear when examining the process metrics for the Moderate Risk and 
High Risk Interventions. (1) The Post-Discharge Phone Call intervention shows a sharp 
increase of almost 50% at the Low/Moderate Risk Threshold (and commensurate sharp 
decrease at the High Risk/Super Utilizer threshold, where the Super Utilizer team is 
expect to subsume this responsibility for post-discharge contact), a pattern that suggests 
consistent and correct targeting of the process based on the planned structural of the 
BMC initiative. Performance rates still fall far short of 100% even among the targeted 
population, though this may suggest additional staffing needs to reach the full cohort of 
patients. Similarly, among the interventions in the High Risk Bundle, both the Admission 
and Discharge Medication Reconciliation interventions demonstrate a dramatic increase 
at the planned Moderate/High Risk cutoff point, again suggesting delivery of the planned 
processes to the appropriate patient population. The absolute levels of performance of 
both Medication Reconciliations remained high across the target population— 
approximately 90% for admission and near 80% for discharge. (2) Within the High Risk 
Bundle, the Social Work Evaluation intervention showed a clear ceiling effect with 
relatively high rates of performance for all patients regardless of risk score, suggesting 
the BMC Readmission Reduction Intervention had limited effect on the provision of 
social worker evaluations. (3) Appointment scheduling prior to discharge, another 




worker evaluation. There was low performance of pre-discharge appointment scheduling 
for all patients regardless of risk score, suggesting that there may have been barriers to 
implementation of this planned structural change. 
 
The 30-day readmission rates both before and after the intervention show a similar 
pattern across the range of risk scores (Figure 5). An examination of the readmission rate 
for patients near the Low/Moderate risk threshold show there was no significant 
difference in the pre-post readmission rate for our “control group” of risk scores—near 
the threshold but not assigned to receive a post-discharge phone call—compared to the 
patients near the threshold who were assigned the intervention. This result held for 
multiple sized bandwidths of scores, suggesting that the Post-Discharge Phone Call did 
not have an effect on readmission rates for the targeted population. Similarly small, non-
significant effects were found at the Moderate/High Risk threshold. A substantial 
increase in re-admissions was observed above the High Risk threshold, among patients 
assigned to the Super Utilizer team, however the result did not rise to the level of 
statistical significance. Either a null result or a paradoxical increase in readmission for the 
Super Utilizer Team would be consistent with the existing literature suggesting that 
similar interventions with high levels of patient-clinician contact may lower the threshold 
for readmission to the hospital.29,30 
 
The results of this analysis indicate that none of the BMC Readmission Reduction 




of the risk groups. There are several possible explanations for such a result. The 
incomplete implementation of certain planned components of the initiative—i.e. the 
Discharge Phone Call and the Schedule Follow-up Appointments—may have attenuated 
the effect on readmission, especially within the High Risk Bundle where interventions 
were envisioned to be synergistic. The process metrics alone do not tell the whole story, 
such binary instruments record only if the intervention was documented as performed. 
Specifically, the discharge phone call metric only measures if a call was attempted, but 
not if the patient was reached or if meaningful contact was made. The process measures 
also provide no information on the quality of the performed intervention. For example, 
individual pharmacists may conduct a medication reconciliation differently with some 
focused primarily on maintaining an accurate medication list and others more focused on 
patient education and comprehension. Additionally, due to data limitations, little is 
known about the process of implementation of the Super User team intervention. Finally, 
the chosen interventions themselves may have had an unintended effect in a safety-net 
population. For example, a discharge phone call may not be the most effective means to 
maintain contact with a low income and transient population with intermittent access to a 
phone. Similarly, the Super Utilizer team may have uncovered unmet medical need in 
recently discharge outpatients, which might quite appropriately increase utilization and 
readmissions.  
 
There are limitations to this effectiveness analysis of the BMC Readmission Reduction 




the cutoff and do not necessarily rule out heterogeneous treatment effects for patients 
further from the risk threshold. Given the smaller distribution of patients at the highest 
risk score, the present sample size may have been underpowered to detect a change in 
readmission rates at those thresholds. Additionally, the flexibility and unstandardized 
approach of the Super Utilizer team limits broader interpretation of the results for this 
intervention. The Super Utilizer team as implemented did not significantly reduce 
readmission rates. However, it remains unclear if this was a result of limited Super 
Utilizer Team contact (i.e. did the team see all targeted patients), ineffective actions taken 
by the team, individual staffing issues, or general lack of effectiveness of this type of 
individualized case management. It is also possible that any reductions in unnecessary re-
admissions were offset by increases in re-admissions satisfying unmet need – indeed, this 
might explain the apparent – though non-significant – increase in readmissions in this 
group. A future qualitative or mixed methods study of the Super Utilizer Team 
intervention may provide more insight into and context for the team’s measured 
performance.  
 
It also important to note the possible underperformance of the readmission risk score 
itself in predicting readmission rates for those at this highest risk scores. Those with a 
risk score of above 16 show a trend towards lower readmission rates both before and after 
the intervention. The functional form of the pre- and post-intervention 30-day 
readmission rates remained very similar (Figure 5b), thus the performance of the risk 




effectiveness. However, a future iteration of the BMC Readmission Initiative may 
examine refinements to the risk score methodology to enhance identification of patients 
at the very highest risk.  
 
Implications for a Learning Health System  
Even the apparent ineffectiveness of this initial implementation of the BMC Readmission 
Reduction Initiative provides stakeholders with valuable knowledge. It allows an 
opportunity to realize a key tenet of the Learning Health System as envisioned by the 
IOM in which “internal data and experience [are] systematically integrated with external 
evidence and that knowledge is put into practice”1.  This study provides a means to link 
structure, process and outcomes for a large-scale, continuous quality improvement 
initiative.  It identified areas to improve implementation and provided information on the 
effect of three separate sets of interventions on readmission rates with relatively strong 
casual inference. The lessons derived can be applied to redirect resources, discontinue or 
redesign ineffective interventions and identify areas were further qualitative examination 
of the program may be valuable.   
 
There are several aspects of model used here to evaluate the effectiveness of a specific 
readmissions initiative that are generally applicable to advancing the LHS. (1) Using a 
risk score—or other clinical indicator—to assign a treatment or intervention allows 
stakeholders to target scare resources to patients most in need, while at the same time 




develop strong internal knowledge without the pragmatic and ethical issues that often 
limit use of randomized trials.  (2) The use of a quasi-experimental design allows health 
system leaders to draw conclusions with stronger causal inference than the simple pre-
post comparison of means or the run charts of outcomes often used in local quality 
improvement projects48. (3) The readmissions analysis required only operational data 
extracted from electronic medical record, decreasing the cost and complexity in 
evaluating a large-scale initiative. Such data collection methods also ensure that 
measuring further iterations of a project do not require large amounts of additional 
infrastructure. (4) The model is broadly applicable to outcomes beyond 30-day 
readmissions. For example, one could envision the same analytic model applied to a 
large-scale diabetes care improvement effort.  Stakeholders would begin by designing 
evidence-informed structural changes (a new high-risk diabetes clinic staffed by 
pharmacists) targeted to those with the highest Hemoglobin A1C values (A1C > 10%). 
Then they would track measurable changes in processes of care (frequency of A1C 
testing, medication adherence, insulin initiation, etc.) and use regression discontinuity or 
other quasi-experimental design to rigorously examine the effectiveness of the initiative 
in improving diabetes control, all using data extracted from an EMR.  
 
Thus the significance of this examination of the BMC Readmission Reduction Initiative 
is multifold. The results have generated useful information to guide internal decision-
making. This study also adds to the body of literature examining the effectiveness of 




the analytic approach advanced tenets of the Learning Health System that may prove 





Figures and Tables  
 
Table 1:  Relative Weight of Factors Used to Calculate the BMC Readmission Risk Score  
Patient characteristics and their relative weight used to calculate the BMC Readmission Risk 
Score.  The score is available at the beginning of each hospital admission and each patient can 






Table 2: Components of the BMC Readmission Reduction Intervention 
 
Each admitted patient is identified as part of one of four risk cohorts based on their BMC 
Readmission Risk Score.  Each cohort is assigned to receive a bundle of remission reduction 






Figure 1: The Conceptual Model 
  
Conceptual model explaining the relationship of structural changes made by the BMC 
administration to process measures as actually performed and the ultimate effect on the 30-day 





Figure 2: Distribution of Risk Scores Before and After Implementation  
 
Distribution of BMC Risk Scores for patient visits by relative frequency with Pre representing 
visits that occurred in the study period prior to implementation of the readmission reduction 






Figure 3: Proportion of patients receiving Post-discharge Phone Call (Moderate and 
High Risk Groups) 
 
 
Proportion of patient visits after implementation where a post-discharge phone call was 
attempted, binned by Risk Score with associated standard error bars. Low/Moderate and 






Figure 4a: Proportion of patients receiving a Scheduled Follow-Up Appointment (High 
Risk Group, Score>8) 
 
 
Proportion of patient visits after implementation where a post-discharge follow-up appointment 
was made prior to discharge, binned by Risk Score with associated standard error bars. 






Figure 4b: Proportion of patients receiving Admission Medication Reconciliation (High 
Risk Group, Score>8)  
 
  
Proportion of patient visits after implementation where an admission medication reconciliation 
was performed on admission, binned by Risk Score with associated standard error bars. 






Figure 4c: Proportion of patients receiving Discharge Medication Reconciliation (High 
Risk Group, Score>8) 
 
Proportion of patient visits after implementation where a discharge medication reconciliation 
was performed on admission, binned by Risk Score with associated standard error bars. 






Figure 4d: Proportion of patients receiving Social Work Evaluation (High Risk Group, 
Score>8)  
 
Proportion of patient visits after implementation where a psychosocial evaluation was performed 
by a social worker during admission, binned by Risk Score with associated standard error bars. 






Figure 5a: 30day Readmission Rate in the Pre-implementation Period  
 
Proportion of patients in the pre-Implementation period subsequently readmitted within 30-days 






Figure 5b: 30day Readmission Rate in the Pre- and Post-Implementation Period 
 
Proportion of patients readmitted within 30-days of discharge, with visits subset by Pre- (blue) 






Figure 5c: Difference in 30day Readmission Rate for Patients at Each Risk Score  
  
Difference in the proportion of patient readmitted in 30day in the Post-implementation period 







Table 3a: Readmission Rates for Low Risk vs. Moderate Risk Threshold 











   
4 No 11.55 12.00 0.45 
5 Yes 11.16 14.29 3.12 
Bandwidth #2 
(N=10,489) 
   
3+4 No 10.67 12.56 1.90 
5+6 Yes 13.02 15.32 2.29 
Bandwidth #3 
(N=16,880)  
   
2+3+4 No 9.39 11.56 2.17 
5+6+7 Yes 13.78 16.79 3.01 
30 day readmission rates Pre, Post and the difference Post implementation for patient visits that 
fall within certain bins of risk score and whether patients in that risk group were assigned to get 
the moderate risk bundle of interventions.  
	
Table 3b: Difference-in Difference Estimates for Low Risk vs. Moderate Risk Threshold 
F/U Phone Call vs. No F/U 
Phone Call Diff-in-Diff (%) 95% CI p-value 
Bandwidth 1 (4 vs. 5) 2.67 -1.27, 6.61 0.18 
Bandwidth 2 (3+4) vs. 5+6)  0.40 -2.34, 3.14 0.77 
Bandwidth 3 (2+3+4 vs. 5+6+7) 0.84 -1.30, 2.98 0.44 
Estimate of effect of the moderate risk bundle of interventions from three bandwidths of data 
around the low/moderate risk threshold. Estimates derived from the difference in difference 





Table 4a: Readmission Rates for Moderate Risk vs. High Risk Threshold 










   
8 No 19.58 20.81 1.22 
9 Yes 19.57 21.80 2.24 
Bandwidth #2 
(N=7037) 
   
7+8 No 17.19 20.14 2.95 
9+10 Yes 20.69 24.05 3.37 
Bandwidth #3 
(N=10,705) 
   
6+7+8 No 16.19 18.61 2.42 
9+10+11 Yes 21.70 25.02 3.32 
30 day readmission rates Pre, Post and the difference post-implementation for patient visits that 
fall within certain bins of risk score and whether patients in that risk group were assigned to get 
the high risk bundle of interventions.  
 
Table 4b: Difference-in Difference Estimates for Moderate Risk vs. High Risk Threshold 
High Risk Bundle vs. No High Risk 
Bundle Diff-in-Diff (%) 95% CI p-value 
Bandwidth 1 (8 vs. 9) 1.02 -4.65, 6.68 0.73 
Bandwidth 2 (7+8) vs. 9+10)  0.42 -3.93, 4.76 0.85 
Bandwidth 3 (6+7+8 vs. 9+10+11) 0.90 -2.90, 4.71 0.64 
Estimate of effect of the high-risk bundle of interventions from three bandwidths of data around 
the moderate/high risk threshold. Estimates derived from the difference in difference model and 





Table 5a: Readmission Rates for the High Risk vs. Super Utilizer Threshold 










   
13 No 39.35 36.71 -2.64 
14 Yes 43.02 48.45 5.43 
Bandwidth #2 
(N=2554) 
   
12+13 No 36.71 35.41 -1.29 
14+15 Yes 42.11 47.67 5.56 
Bandwidth #3 
(N=3315) 
   
11+12+13 No 34.04 33.56 -0.48 
14+15+16 Yes 41.59 46.99 5.36 
30 day readmission rates Pre, Post and the difference post-implementation for patient visits that 
fall within certain bins of risk score and whether patients in that risk group were assigned to get 
the super utilizer team interventions.  
 
Table 5b: Difference-in Difference Estimates for High Risk vs. Super Utilizer Threshold  
SU Team Assigned vs. No SU Team 
Assigned  
Diff-in-Diff (%) 95% CI p-value 
Bandwidth 1 (13 vs. 14) 8.07 -2.33, 18.46 0.13 
Bandwidth 2 (12+13 vs. 14+15)  6.85 -1.26, 14.96 0.10 
Bandwidth 3 (11+12+13 vs. 14+15+16) 5.87 -1.27, 14.21 0.11 
Estimate of effect of the super utilizer team from three bandwidths of data around the high 
risk/super utilizer threshold. Estimates derived from the difference in difference model and 
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